Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diaryl propionyl hydroxamic compound and preparation method and use thereof

A technology of diaryl propionyl hydroxamic acid and diaryl propionyl hydroxamic acid, which is applied in the field of preparation of anti-gastritis and gastric ulcer drugs, and can solve problems such as instability, low activity, and hindering application

Inactive Publication Date: 2013-04-03
杨秀菊
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are some shortcomings in the existing urease inhibitors. For example, acetohydroxamic acid has some side effects due to its low activity and large dosage, while the highly active phosphodiamide urease inhibitors are unstable in acidic environments, hindering its clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diaryl propionyl hydroxamic compound and preparation method and use thereof
  • Diaryl propionyl hydroxamic compound and preparation method and use thereof
  • Diaryl propionyl hydroxamic compound and preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Example 1: Preparation of 3-(3-hydroxyphenyl)-3-(2,3,4-trihydroxyphenyl)-3-hydroxypropionylhydroxamic acid (50)

[0039] Add 2.52g pyrogallic acid to 20ml BF 3 ·Et 2 O, then add 3.31g of m-hydroxybenzoic acid, heat up to 85°C and react for 15h. After the reaction is complete, pour it into the aqueous solution of AcONa, filter with suction, wash, and EtOH-H 2 O recrystallized to obtain 3.78 g of 3-hydroxyphenyl-2,3,4-trihydroxyphenyl ketone, yield 77%;

[0040] 2.46g of 3-hydroxyphenyl-2,3,4-trihydroxyphenyl ketone, 6.5g of Zn powder, 4.82g of NH 4 Cl and 4.45mL ethyl bromoacetate were ground together until uniform. After standing at room temperature for 18 h, pour saturated NH 4 Cl solution, AcOEt extraction, anhydrous MgSO 4 Dry, evaporate the solvent, purify with silica gel column, eluent volume ratio: AcOEt:petroleum ether=1:2, get 3-hydroxyl-3-(3-hydroxyphenyl)-3-(2,3,4- Trihydroxyphenyl) ethyl propionate, 2.17g, productive rate 65%;

[0041] Dissolve 1.67g o...

Embodiment 2

[0043] According to the method similar to Example 1, using different substituted forms of benzoic acid and benzene as raw materials, the diaryl propionylhydroxamic acid series compounds 1-86 listed in Table 1 were synthesized.

[0044] Each R group of diaryl propionyl hydroxamic acid series compound in the general formula I of table 1

[0045] serial number

[0046] serial number

[0047] serial number

[0048] serial number

[0049] Note: The initial raw materials were purchased from aldrich company

Embodiment 3

[0050] Embodiment 3: the inhibitory enzyme activity of compound

[0051] Add 25 μL of Jack bean urease (4U) and 25 μL (1 mM) of the test compound solution to the 96-well plate, incubate at 37 °C for 2 h, then add 55 μL of phosphate buffer containing 100 mM urea and 100 mM, and incubate at 30 °C. Incubate at ℃ for 15 min, add 45 μL of phenol reagent (mixed solution containing 1% phenol and 0.005% sodium nitroprusside) and 70 μL alkali reagent (mixed solution of NaOCl containing 0.5% NaOH and 0.1% active chlorine), at room temperature After standing for 50 minutes, measure the OD value at 630nm with a microplate reader, and the percentage inhibition rate is calculated according to the following formula:

[0052]

[0053] All experiments were performed in solutions at pH 8.2 (0.01M K 2 HPO 4 , 1mM EDTA, 0.01M LiCl), the level of activity is measured by the half-inhibition rate IC 50 to indicate that the IC 50 The smaller the value, the higher the activity of the compound. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a diaryl propionyl hydroxamic compound, which has the following general formula of structure shown in the specification. The compound has relatively good inhibitory action on urease, and can be used to prepare drugs for resisting gastritis, gastric ulcer, lithangiuria and the like. The invention discloses a preparation method of the compound.

Description

technical field [0001] The invention relates to a class of diaryl propionyl hydroxamic acid urease inhibitors, a preparation method thereof and their application in the preparation of anti-gastritis and gastric ulcer drugs. technical background [0002] Helicobacter pylari can cause gastritis, gastric ulcer, duodenal ulcer, gastric atrophy, intestinal metaplasia, gastric cancer, gastric lymphoma and other diseases. In 1994, the World Health Organization and the International Cancer Research Center listed H. pylori as the first type of carcinogen. According to statistics, about half of the world's population is infected with H. pylori, and the infection rate is as high as 80-90% in developing countries. The infection rate in our country is about 60%. The detection rate of H.pylori in patients with gastritis is 80-90%, and it is higher in patients with peptic ulcer, reaching more than 95%. More than 90% of duodenal ulcers and about 80% of gastric ulcers are caused by H. pyl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C259/06A61P1/04A61P13/02
Inventor 肖竹平王旭东易利成胡小军周航宇
Owner 杨秀菊
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com